The Valley Desk

NCT05568719 · Interventional trial

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

Overall registry status Recruiting

Phase 3

Conditions Hemophilia A, Hemophilia B

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov